The Lancet. Rheumatology Journal

Overview
Identity
View All

publication venue for

Hip-focused physical therapy versus spine-focused physical therapy for older adults with chronic low back pain at risk for mobility decline (MASH): a multicentre, single-masked, randomised controlled trial.. 6:e10-e20. 2024
Global, regional, and national burden of rheumatoid arthritis, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021.. 5:e594-e610. 2023
Global, regional, and national burden of osteoarthritis, 1990-2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021.. 5:e508-e522. 2023
Should race be considered in diagnosing giant cell arteritis? - Authors' reply.. 5:e372-e373. 2023
Giant cell arteritis can occur in people of colour.. 5:e175-e177. 2023
Navigating use of rituximab during the COVID-19 pandemic.. 5:e63-e64. 2023
Omicron breakthrough infections in patients with immune-mediated inflammatory diseases.. 4:e751-e752. 2022
Effectiveness of COVID-19 vaccination in immune-mediated inflammatory diseases.. 4:e380-e382. 2022
COVID-19 vaccine perceptions and uptake: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey.. 4:e237-e240. 2022
Long-term use of immunosuppressive medicines and in-hospital COVID-19 outcomes: a retrospective cohort study using data from the National COVID Cohort Collaborative.. 4:e33-e41. 2021
Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study.. 3:e855-e864. 2021
Immediate effect of the COVID-19 pandemic on patient health, health-care use, and behaviours: results from an international survey of people with rheumatic diseases.. 3:e707-e714. 2021
Clinical pathways for patients with giant cell arteritis during the COVID-19 pandemic: an international perspective.. 3:e71-e82. 2020